Regor Therapeutics Announces Completion of $90 Million Series ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI, Feb. 19, 2021 /PRNewswire-AsiaNet/ -- Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing.Found...
Authors: LATEST ASIANET NEWS RELEASES